Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/8729
DC FieldValueLanguage
dc.contributor.authorAvital I.en
dc.contributor.authorLangan R.en
dc.contributor.authorSummers T.en
dc.contributor.authorSteele S.en
dc.contributor.authorWaldman S.en
dc.contributor.authorBackman V.en
dc.contributor.authorYee J.en
dc.contributor.authorNissan A.en
dc.contributor.authorYoung P.en
dc.contributor.authorWomeldorph C.en
dc.contributor.authorMancusco P.en
dc.contributor.authorMueller R.en
dc.contributor.authorNoto K.en
dc.contributor.authorGrundfest W.en
dc.contributor.authorBilchik A.en
dc.contributor.authorProtić, Mlađanen
dc.contributor.authorDaumer M.en
dc.contributor.authorEberhardt J.en
dc.contributor.authorMan Y.en
dc.contributor.authorBrücher B.en
dc.contributor.authorStojadinović, Aleksandraen
dc.date.accessioned2019-09-30T09:10:45Z-
dc.date.available2019-09-30T09:10:45Z-
dc.date.issued2013-08-30en
dc.identifier.urihttps://open.uns.ac.rs/handle/123456789/8729-
dc.description.abstractColorectal cancer (CRC) is the third most common cause of cancer-related death in the United States (U.S.), with estimates of 143,460 new cases and 51,690 deaths for the year 2012. Numerous organizations have published guidelines for CRC screening; however, these numerical estimates of incidence and disease-specific mortality have remained stable from years prior. Technological, genetic profiling, molecular and surgical advances in our modern era should allow us to improverisk stratification of patients with CRC and identify those who may benefit from preventive measures, early aggressive treatment, alternative treatment strategies, and/or frequent surveillance for the early detection of disease recurrence. To better negotiate future economic constraints and enhance patient outcomes, ultimately, we propose to apply the principals of personalized and precise cancer care to risk-stratify patients for CRC screening (Precision Risk Stratification- Based Screening, PRSBS). We believe that genetic, molecular, ethnic and socioeconomic disparities impact oncological outcomes in general, those related to CRC, in particular. This document highlights evidence-based screening recommendations and risk stratification methods in response to our CRC working group private-public consensus meeting held in March 2012. Our aim was to address how we could improve CRC risk stratification-based screening, and to provide a vision for the future to achieving superior survival rates for patients diagnosed with CRC. © Ivyspring International Publisher.en
dc.relation.ispartofJournal of Canceren
dc.titleEvidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer: Lessons learned from the us armed forces: Consensus and future directionsen
dc.typeOtheren
dc.identifier.doi10.7150/jca.5834en
dc.identifier.scopus2-s2.0-84883027640en
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/84883027640en
dc.relation.lastpage192en
dc.relation.firstpage172en
dc.relation.issue3en
dc.relation.volume4en
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptKatedra za hirurgiju-
crisitem.author.deptKatedra za pedijatriju-
crisitem.author.parentorgMedicinski fakultet-
crisitem.author.parentorgMedicinski fakultet-
Appears in Collections:MDF Publikacije/Publications
Show simple item record

SCOPUSTM   
Citations

19
checked on May 10, 2024

Page view(s)

82
Last Week
19
Last month
0
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.